We are Sorry, This Page doesn't Exist
AstraZeneca"s durvalumab granted orphan designation as lung cancer treatment
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
The Daily Biotech Pulse: FDA Approves Karyopharm"s Blood Cancer Treatment, Grifols" Immunodeficiency Drug; ESMO, ISTH Conferences In The Spotlight
The following is a roundup of the top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs July 3.) • Abbott Laboratories (NYSE: ABT) read more.....»»
Understanding sarcoma: from diagnosis to treatment
A cancer diagnosis can be scary and confusing, especially for a patient receiving a sarcoma diagnosis. What is sarcoma? Sarcoma is a rare cancer of the soft tissues and bone. Most types of cancer originate in the epithelial linings that cover ex.....»»
AstraZeneca"s Lynparza approved as 1st line ovarian cancer maintenance treatment
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
FDA Greenlights Merck"s Blockbuster Drug Keytruda For First-Line Treatment Of Head, Neck Cancer
Keytruda, Merck & Co., Inc. read more.....»»
Merck"s Keytruda no better than chemo as a first-line treatment for gastric cancer, according to Phase 3 study results
Merck & Co. Inc. said Friday that a Phase 3 trial evaluating Keytruda as a first-line treatment for gastric cancer failed to show improvement in patients' overall or progression-free survival when compared with chemotherapy. Shares of th.....»»
Novartis non-small cell lung cancer treatment granted orphan status
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AstraZeneca says FDA approves Tagrisso as 1st-line treatment for certain cancers
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Merck Wins Big Against Rivals in Lung Cancer Study Survival Rates
Lung cancer may have just met a new standard of care. On top of that, it would be considered a new standard as a first line of care in lung cancer and longer overall survival rates......»»
Merck Cements Lead in Lung Cancer as Bristol-Myers Fizzles
Merck & Co. might have just shut the door on rival Bristol-Myers Squibb Co. as investors weigh new data that could reshape the treatment of lung cancer, by far the deadliest form of cancer in the U.S......»»
Shire sells cancer drugs to Servier as Takeda circles
Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan's Takeda Pharmaceutical, is selling its oncology business.....»»
Shire sells cancer drugs to Servier as Takeda circles
Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan's Takeda Pharmaceu.....»»
"We are going to have lung cancer patients living longer and better:" A new kind of cancer treatment is about to change how we treat the disease (MRK, BMS)
Wikimedia Commons New cancer treatments that harness the body's immune system are ready to go mainstream. In data presente.....»»
Shire sells cancer drugs to Servier for $2.4 billion as Takeda circles
LONDON (Reuters) - Shire , the London-listed rare diseases specialist that is a potential takeover target for Japan's Takeda Pharmaceutical , is selling its oncology business to unlisted French drugmaker Servier for $2.4 billion......»»
Merck Tackles Front-Line Lung Cancer In Latest Trial Win
Merck Tackles Front-Line Lung Cancer In Latest Trial Win.....»»
Merck Moves Ahead With Late-Stage Trial Win
Shares of Merck had a boost early Monday after the firm announced that its Phase 3 trial of Keytruda for the treatment of metastatic non-small cell lung cancer met its primary endpoint......»»
Merck Appears Unstoppable In Treating Front-Line Lung Cancer
Merck Appears Unstoppable In Treating Front-Line Lung Cancer.....»»
Roche Won"t Go Down Without A Fight In The Front-Line Lung Cancer Space
Roche Won"t Go Down Without A Fight In The Front-Line Lung Cancer Space.....»»
Merck Steals The Show At ASCO 2018 With Impressive Front-Line Lung Cancer Data
Merck Steals The Show At ASCO 2018 With Impressive Front-Line Lung Cancer Data.....»»